The committee favors marketing the infliximab biosimilar product Zessly for treatment of rheumatoid arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and psoriasis.
International Approvals …read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
Nice posts! 🙂
___
Sanny